On the Cusp of Change

Parenteral drug manufacturers are sharpening capabilities and coming into their own

PM1606 WebLeadImage 295X269 copy

The changing pharmaceutical landscape is a popular discussion point as of late. Armed with a fresh, non-blockbuster-reliant business model and treatment options that are expanding from small molecules to a range of new, more targeted therapies, the industry is at what PwC calls, “a critical juncture.” Parenteral drug delivery is the second largest segment of this transformative pharmaceutical market — eclipsed only by the more mature oral solid dosage forms — accounting for nearly 30 percent of total pharma market share. According to Freedonia Group research, the market for parenteral drug delivery products is projected to rise over 10 percent annually to $86.5…

Full Story

Don't Miss These Pharma Manufacturing Exclusives

Fundamentals

On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Ask the Expert

We've assembled a roster of leading authorities in many fields to help you address technical issues. Pose a question or browse previous questions to find helpful answers.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Specifying Instruments to Meet Pharmaceutical Hygienic Requirements

    By Ron Pozarski, senior industry manager, Emerson Process Management; and Emily Saopraseuth, product manager, Rosemount Pressure

    Pharmaceutical manufacturing is heavily regulated, though standards designed to guide the selection of measurement and analytical instrumentation for sterile processes are not completely defined. To fill the void, some companies — and even individual plants — have created their own internal…

    Full Story
  • Netflix and Pill

    By Karen Langhauser, Chief Content Director

    The other night I happened to see the first movie in the “Paranormal Activity” series. If you aren’t familiar with the plot, it’s a horror flick based around a family haunted by demons. The uniqueness is in the filming, though; the series is filmed as if it was actual footage, recorded via…

    Full Story
  • Oligonucleotides: Opportunities, Pipeline and Challenges

    By Tracy Tredenick, Head of Regulatory and Quality Assurance, BioTechLogic

    Although meaningful progress toward the development of oligonucleotide therapeutics began in the 1970s, nearly a half century later, only three oligonucleotide drugs have been approved by the FDA. However, the field is gaining momentum and the clinical benefits of the more than 135 oligonucleotide…

    Full Story
  • MES Systems Help Facilitate Modern Regulatory Compliance

    By Lars Hornung, senior director global sales, Werum IT Solutions GmbH

    Manufacturing Execution Systems (MES) enable pharmaceutical manufacturers to improve performance and reduce operational cost, while simultaneously increasing compliance with regulatory requirements. The MES plays a critical role at the center of the manufacturing operation, connecting shop-floor…

    Full Story
  • Putting Quality on Trial

    By Matthias Evers, Shane Gannon, Lorenzo Positano, and Doerte Seeger, McKinsey & Company

    Drug development programs are no exception to the rising importance of quality for pharmacos. Increasing demands by regulators and business partners have made it imperative for quality functions to have scientifically sound processes for review and assurance, rather than solely fulfilling the…

    Full Story
  • Plant Transient Technology Expedites Scale-Up

    By Barry Holtz, President, iBio CMO; and Sylvain Marcel, PhD, Senior Scientist, iBio CMO

    Once a drug candidate has been selected, the ability to rapidly scale-up production is critical in the business and clinical timeline. Providing materials for late-phase clinical trials and product launch directly affects time to market. New platforms and research have drastically improved this…

    Full Story

Latest Products